• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

强直性脊柱炎患者慢性肾脏病发病率及其与长期使用非甾体抗炎药的相关性:一项基于全国人口的研究。

Incidence rate of chronic kidney disease and its association with long-term nonsteroidal anti-inflammatory drug use in ankylosing spondylitis: A nationwide population-based study.

机构信息

Department of Internal Medicine, Inje University Seoul Paik Hospital, Inje University College of Medicine, Seoul, South Korea.

Department of Clinical Epidemiology and Biostatistics, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea.

出版信息

Int J Rheum Dis. 2024 Aug;27(8):e15310. doi: 10.1111/1756-185X.15310.

DOI:10.1111/1756-185X.15310
PMID:39180303
Abstract

AIM

Ankylosing spondylitis (AS) predominantly affects the spine and sacroiliac joints, with rare renal involvement. We investigated the incidence rate and risk factors for chronic kidney disease (CKD) in patients with AS and its relationship with long-term nonsteroidal anti-inflammatory drug (NSAID) use.

METHODS

We retrospectively analyzed data of patients diagnosed with AS from the Korean National Health Insurance service. The 3-month, 6-month, and 1-year Assessment of SpondyloArthritis International Society (ASAS) NSAID Intake Scores were categorized into four groups, as follows: =0, >0 and ≤33.3, 33.3-66.6, and >66.6.

RESULTS

Of the 12 000 patients with AS, 150 were identified with CKD, and the incidence rate was 4.64 per 10 000 patient-years. Factors significantly associated with CKD included age ≥60 years, Charlson Comorbidity Index, hypertension, and diabetes mellitus. In the nested case-control analysis, among the ASAS NSAIDs Intake Scores for 0-365 days from diagnosis, the ≥66.6 group had a significantly lower odds ratio than those of the =0 group.

CONCLUSION

The present study established the incidence rate of CKD in Korean patients with AS. Though older age and comorbidities were found to be associated with a higher CKD risk, long-term NSAID use was associated with a lower risk. Therefore, the optimal use of NSAIDs in inflammatory diseases requires extensive research.

摘要

目的

强直性脊柱炎(AS)主要影响脊柱和骶髂关节,罕见肾脏受累。我们研究了 AS 患者慢性肾脏病(CKD)的发病率和危险因素及其与长期使用非甾体抗炎药(NSAID)的关系。

方法

我们回顾性分析了韩国国家健康保险服务中诊断为 AS 的患者数据。将 3 个月、6 个月和 1 年的评估强直性脊柱炎国际协会(ASAS)非甾体抗炎药摄入评分分为四组:=0、>0 且≤33.3、33.3-66.6 和>66.6。

结果

在 12000 名 AS 患者中,有 150 名患者患有 CKD,发病率为每 10000 患者年 4.64 例。与 CKD 显著相关的因素包括年龄≥60 岁、Charlson 合并症指数、高血压和糖尿病。在巢式病例对照分析中,从诊断开始至 0-365 天的 ASAS NSAIDs 摄入量评分中,≥66.6 组的比值比明显低于=0 组。

结论

本研究确定了韩国 AS 患者 CKD 的发病率。虽然年龄较大和合并症与更高的 CKD 风险相关,但长期 NSAID 使用与较低的风险相关。因此,需要对炎症性疾病中 NSAIDs 的最佳使用进行广泛研究。

相似文献

1
Incidence rate of chronic kidney disease and its association with long-term nonsteroidal anti-inflammatory drug use in ankylosing spondylitis: A nationwide population-based study.强直性脊柱炎患者慢性肾脏病发病率及其与长期使用非甾体抗炎药的相关性:一项基于全国人口的研究。
Int J Rheum Dis. 2024 Aug;27(8):e15310. doi: 10.1111/1756-185X.15310.
2
Use of Nonsteroidal Anti-Inflammatory Drugs and Risk of Chronic Kidney Disease in Subjects With Hypertension: Nationwide Longitudinal Cohort Study.高血压患者使用非甾体抗炎药与慢性肾脏病风险:全国性纵向队列研究
Hypertension. 2015 Sep;66(3):524-33. doi: 10.1161/HYPERTENSIONAHA.114.05105. Epub 2015 Jul 13.
3
The Prevalence of Renal Impairment in Patients with Spondyloarthritis: Results from the International ASAS-COMOSPA Study.脊柱关节炎患者肾功能损害的患病率:来自国际 ASAS-COMOSPA 研究的结果。
J Rheumatol. 2018 Jun;45(6):795-801. doi: 10.3899/jrheum.170133. Epub 2018 Apr 15.
4
Risk of cardiovascular disease with high-dose versus low-dose use of non-steroidal anti-inflammatory drugs in ankylosing spondylitis.强直性脊柱炎中高剂量与低剂量使用非甾体抗炎药的心血管疾病风险
Ann Rheum Dis. 2024 Jul 15;83(8):1028-1033. doi: 10.1136/ard-2023-225406.
5
Evaluation of the nonsteroidal anti-inflammatory drug-sparing effect of etanercept in axial spondyloarthritis: results of the multicenter, randomized, double-blind, placebo-controlled SPARSE study.评估依那西普在轴性脊柱关节炎中减少非甾体抗炎药用量的效果:多中心、随机、双盲、安慰剂对照的SPARSE研究结果
Arthritis Res Ther. 2014 Nov 27;16(6):481. doi: 10.1186/s13075-014-0481-5.
6
Non-steroidal anti-inflammatory drugs (NSAIDs) for axial spondyloarthritis (ankylosing spondylitis and non-radiographic axial spondyloarthritis).用于中轴型脊柱关节炎(强直性脊柱炎和非放射学中轴型脊柱关节炎)的非甾体抗炎药
Cochrane Database Syst Rev. 2015 Jul 17;2015(7):CD010952. doi: 10.1002/14651858.CD010952.pub2.
7
The relationship between long-term use of nonsteroidal anti-inflammatory drugs and kidney function in patients with ankylosing spondylitis.强直性脊柱炎患者长期使用非甾体抗炎药与肾功能的关系。
J Rheum Dis. 2023 Apr 1;30(2):126-132. doi: 10.4078/jrd.2023.0006. Epub 2023 Mar 17.
8
Prevalence and risk factors of anterior atlantoaxial subluxation in ankylosing spondylitis.强直性脊柱炎寰枢关节前脱位的患病率及危险因素。
J Rheumatol. 2012 Dec;39(12):2321-6. doi: 10.3899/jrheum.120260. Epub 2012 Oct 1.
9
Kunxian capsules in the treatment of patients with ankylosing spondylitis: a randomized placebo-controlled clinical trial.昆仙胶囊治疗强直性脊柱炎患者:一项随机安慰剂对照临床试验。
Trials. 2016 Jul 22;17(1):337. doi: 10.1186/s13063-016-1438-6.
10
Retrospective pharmacovigilance analysis of nonsteroidal anti-inflammatory drugs-induced chronic kidney disease.非甾体抗炎药相关性慢性肾脏病的回顾性药物警戒分析。
Indian J Pharmacol. 2021 May-Jun;53(3):192-197. doi: 10.4103/ijp.IJP_704_20.

引用本文的文献

1
Prevalence and Pathogenetic Mechanisms of Chronic Kidney Disease in Autoimmune-Mediated Systemic Diseases.自身免疫介导的全身性疾病中慢性肾脏病的患病率及发病机制
J Clin Med Res. 2025 Jul 31;17(7):375-385. doi: 10.14740/jocmr6271. eCollection 2025 Jul.